Treace Medical Concepts (TMCI) Non Operating Investment Income (2022 - 2026)
Treace Medical Concepts (TMCI) reported Non Operating Investment Income of -$98000.0 for Q1 2026, down 145.0% on a YoY basis from $217777.8 in Q1 2025, and down 790.91% quarter-over-quarter from -$11000.0 in Q4 2025.
Treace Medical Concepts (TMCI) Non Operating Investment Income (2022 - 2026) Analysis & Trends
Treace Medical Concepts has reported Non Operating Investment Income for 5 years, with the latest figure at -$98000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Investment Income fell 145.0% year-over-year to -$98000.0; the trailing twelve-month figure through Mar 2026 stood at -$83000.0 (down 591.67% YoY), and the FY2025 full-year result was -$25000.0, up 62.12% from the prior year.
- Non Operating Investment Income for Q1 2026 stood at -$98000.0, down from -$11000.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $311000.0 in Q4 2023, with the low at -$163000.0 in Q2 2023.
- Historically, Non Operating Investment Income has averaged -$1857.1 across 5 years, with a median of -$28000.0 in 2022.
- Annual changes were most pronounced in 2023 — Non Operating Investment Income soared 1251.85% — and 2024, when it plunged 224.14%.
- Treace Medical Concepts' Non Operating Investment Income stood at -$27000.0 in 2022, then soared by 1251.85% to $311000.0 in 2023, then plunged by 130.23% to -$94000.0 in 2024, then surged by 88.3% to -$11000.0 in 2025, then plunged by 790.91% to -$98000.0 in 2026.
- The last three Non Operating Investment Income figures came in at -$98000.0 (Q1 2026), -$11000.0 (Q4 2025), and $33000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Treace Medical Concepts | 274.20 Mn | 222.34 Mn | 37.41 Mn | -98,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98,000.00 |
| Mar 31, 2026 | -98,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Sep 30, 2025 | 33,000.00 |
| Sep 30, 2025 | 33,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | -95,000.00 |
| Jun 30, 2024 | -95,000.00 |
| Mar 31, 2024 | -94,000.00 |
| Mar 31, 2024 | -94,000.00 |
| Dec 31, 2023 | 311,000.00 |
| Dec 31, 2023 | 311,000.00 |